Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis
Authors:
- Paolo GisondiPGPaolo Gisondi
- Giovanni TargherGTGiovanni Targher
- Giacomo ZoppiniGZGiacomo Zoppini
- Giampiero GirolomoniGGGiampiero Girolomoni
- 1 October 2009
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 51 (4) , 758-764
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitmentJournal of Experimental Medicine, 2008
- Non-alcoholic fatty liver disease: The mist gradually clearsJournal of Hepatology, 2008
- The Risk of Mortality in Patients With PsoriasisArchives of Dermatology, 2007
- Pathogenesis and clinical features of psoriasisThe Lancet, 2007
- Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatmentJournal of Hepatology, 2007
- Relationship between high-sensitivity C-reactive protein levels and liver histology in subjects with non-alcoholic fatty liver diseaseJournal of Hepatology, 2006
- Prevalence of cardiovascular risk factors in patients with psoriasisJournal of the American Academy of Dermatology, 2006
- Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasisArchives of Dermatological Research, 2006
- Inflammation and insulin resistanceJournal of Clinical Investigation, 2006
- Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2Journal of Hepatology, 2006